RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
2024; Lippincott Williams & Wilkins; Volume: 42; Issue: 19 Linguagem: Inglês
10.1200/jco.23.02110
ISSN1527-7755
AutoresDavid R. Spigel, Afshin Dowlati, Yuanbin Chen, Alejandro Navarro, James Chih‐Hsin Yang, Goran Stojanović, María Jove, Patricia Rich, Zoran Andrić, Yi‐Long Wu, Charles M. Rudin, Huanyu Chen, Li Zhang, Stanley M.H. Yeung, Fawzi Benzaghou, Luis Paz‐Ares, Paul A. Bunn, Philip Clingan, Theresa Hayes, Craig Underhill, Wim Demey, Frédéric Forget, Marc Lambrechts, Kristiaan Nackaerts, Fabio André Franke, Alan A. Azambuja, Rodrigo Régnier Chemim Guimarães, Josiane Mourão Dias, Víctor Sacristán Santos, Bruno Cezar de Mendonça Uchóa, Gustavo Vasconcelos Alves, Cláudia Vaz de Melo Sette, Minghong Bi, Jiuwei Cui, Jian Fang, Jianhua Shi, Ke Wang, Zhen Wang, Xinmin Yu, C. Dayen, Laurent Greillier, Gilles Quéré, Alexander Baraniskin, Helge Bischoff, Frank Griesinger, Cornelius F. Waller, Tibor Csöszi, Gabriella Gálffy, Ibolya Laczó, György Losonczy, S. Tehenes, Angelo Delmonte, Alessandro Follador, Halina Batura‐Gabryel, Piotr Centkowski, Iwona Danielewicz, Andrzej Każarnowicz, Rodryg Ramlau, Alina Muntean, Cristina Oprean, Michael Schenker, Cristina Tiut, Anghel Adrian Udrea, Andrei Ungureanu, Nina Karaseva, Nikolay Kislov, Elena Poddubskaya, Irina Rozhkova, Ekaterina Solovyeva, Anastasia Zimina, Zoran Andrić, Vladimir Kovčin, Marina Petrović, Zorica Radojević, Goran Stojanović, SookHee Hong, Sang‐We Kim, Ki Hyeong Lee, Byoung Yong Shim, M. Alonso Garcìa, Antonio Calles, Vanesa Gutiérrez Calderón, Óscar Juan, B. Massuti Sureda, Alejandro Navarro, Ramón Palmero, Luis Paz-Ares Rodríguez, Ching-Liang Ho, Sheng‐Hao Lin, Chien‐Ying Liu, James Chih‐Hsin Yang, İrfan Çiçin, Mahmut Gümüş, Hakan Harputluoğlu, Mustafa Özgüroğlu, S. Seber, Ahmet Sezer, Hryhoriy Adamchuk, Igor Bondarenko, Yevhen Hotko, Oleh Kobziev, Oleksandr Koshelenko, A. Kurochkin, Yuriy Semegen, Ivan Sinielnikov, Tetiana Tarasenko, Dmytro Trukhin, Jennifer W. Carlisle, Laurie Carr, Arvind Chaudhry, Hongbin Chen, Yuanbin Chen, Afshin Dowlati, Herbert L. Duvivier, W. Jeff Edenfield, Maen Hussein, Robert M. Jotte, Srinivas Jujjavarapu, Brian M. Lingerfelt, Steven McCune, Nagaprasad Nagajothi, Peter Rubin, Katherine A. Scilla, David R. Spigel, Gordan Srkalović, Amy Weise, Richard Zuniga,
Tópico(s)Cancer therapeutics and mechanisms
ResumoThe phase III RESILIENT trial compared second-line liposomal irinotecan with topotecan in patients with small cell lung cancer (SCLC).
Referência(s)